Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
ATHE
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -40.9%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
alterity
therapeutics
announced
after
disease
ath434
trading
data
market
trial
2023
clinical
neurodegenerative
diseases
phase
australia
today
multiple
stocks
ATHE
Alterity Therapeutics Limited American Depositary Shares
StonvexStonvexStonvexStonvex